In Vitro Activity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii. - Test2 - elhamkhani - TriplyDB

In Vitro Activity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii.

In Vitro Activity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii.

http://www.wikidata.org/entity/Q36933389

about

Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae.Emerging Issues and Treatment Strategies in Carbapenem-Resistant Enterobacteriaceae (CRE).Controversies and advances in the management of ventilator associated pneumonia.Eravacycline for treatment of complicated intra-abdominal infections: the fire is not ignited!Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review.New Antibiotics in Development Target Highly Resistant Gram-Negative Organisms.Evaluation of the In Vitro Activity of Eravacycline against a Broad Spectrum of Recent Clinical Anaerobic Isolates.Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.Pharmacokinetics and Comprehensive Analysis of the Tissue Distribution of Eravacycline in Rabbits and Characterization of NOSO-502, a Novel Inhibitor of Bacterial Translation

P2860

Q33816251-D13B3E15-EFB2-4F98-8FD7-6B1E4F8FCDB2 Q39031126-78408E9D-6AB7-4AC2-889D-A3A960FD8F78 Q40054170-FE61A5A8-AD5D-4A41-87B1-BBAFFCAEEA19 Q45787274-7ED2A7E1-BD25-4E77-B7AA-CD759954B770 Q47139448-8A5964B4-7098-400E-A172-B9D72A981828 Q49540457-C37EC70E-9199-4D2E-833A-9A68DFC9BFD8 Q52684509-817D0ADF-A3F4-4C5A-B13B-979CDDB93740 Q52695014-1D046A7E-49B7-4EB3-B5B6-E4B55ADF0785 Q57110876-D8AB72EF-5506-43BF-A70A-C1C127B02023 Q58700580-99990298-EC3E-4E6D-9D13-BFB657607CA5

P2860

In Vitro Activity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii.

http://www.wikidata.org/entity/Q36933389

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

In Vitro Activity of Eravacycl ...... e and Acinetobacter baumannii.

@en

type

label

In Vitro Activity of Eravacycl ...... e and Acinetobacter baumannii.

@en

prefLabel

In Vitro Activity of Eravacycl ...... e and Acinetobacter baumannii.

@en

P1433

Q36933389-8FDECE7D-460D-443B-940B-8D352B552FB6

P1476

Q36933389-9B9E2EE3-E874-4228-8BD9-29EDA75CFA7D

P2093

Q36933389-4D725181-4F69-4531-91D5-C193C0E39AB6

Q36933389-E59CD157-5A83-4001-9E82-4EF91F7F19D8

Q36933389-ECEAD74B-3424-4119-88A0-459D01CE07ED

P2860

Q36933389-07C9BEAF-EB9F-488B-836D-B0C7D41A751C

Q36933389-081CBA0A-168E-4B18-AE93-CD6A2CE9395D

Q36933389-1993254A-E9EF-47A4-AEA4-EEEAF691A1C5

Q36933389-27AB6DCA-35FB-476C-8FD5-7264D7FCE4BE

Q36933389-38B6D3B2-C2C5-4EBF-BB23-08B4C193800E

Q36933389-975F4FA9-3E09-4C74-9A0B-2B3B1E718E3B

Q36933389-9C64C5BD-B097-486E-A402-2BB80A0F625F

Q36933389-A76ADE06-A19A-4B03-97B8-3A3D5977180B

Q36933389-AF20C969-5DD3-4FDD-8B55-EE0B1F14A448

Q36933389-D500DC70-324C-4A79-9ECC-4C4F8FDBB14C

P304

Q36933389-330002CA-BEE1-46E2-AA1E-6434F5E678CB

P31

Q36933389-8617C6CB-1F29-4A35-84EC-B3CB65D462C8

P356

Q36933389-7A8FE7E0-6E0F-44A3-8B2A-3D2AC7039C9F

P407

Q36933389-6D76D922-429E-49EB-9660-C797C045EBF3

P433

Q36933389-853E7084-3521-426A-B55D-FEED9235C633

P478

Q36933389-734FE5D3-9726-40F3-8887-1259961E3AED

P50

Q36933389-E3D2D4AA-A949-4073-A521-F47EC09D1621

P577

Q36933389-D1854EE8-F0E6-400E-B689-D3736F362FED

P698

Q36933389-416E8AA0-9AA0-46CE-ACB1-56AC24F52890

P921

Q36933389-4B9EE2EF-60B0-408A-9D5B-C1DD6FCD093A

Q36933389-B25D9278-F7D1-4C94-81AA-94A9C79AD35A

P932

Q36933389-50CB4265-B666-49EA-A30C-9B445E57AF75

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

In Vitro Activity of Eravacycl ...... e and Acinetobacter baumannii.

@en

P2093

David M Livermore

http://www.w3.org/2001/XMLSchema#string

Marina Warner

http://www.w3.org/2001/XMLSchema#string

Shazad Mushtaq

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of tigecycline for the treatment of severe infectious diseases: an updated meta-analysis of RCTs

Phase I, open-label, safety and pharmacokinetic study to assess bronchopulmonary disposition of intravenous eravacycline in healthy men and women.

Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease.

Antibacterial activity of eravacycline (TP-434), a novel fluorocycline, against hospital and community pathogens.

Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.

Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates.

AcrAB multidrug efflux pump is associated with reduced levels of susceptibility to tigecycline (GAR-936) in Proteus mirabilis.

Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing Klebsiella pneumoniae.

Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports.

Efficacy and safety of tigecycline: a systematic review and meta-analysis.

P304

3840-3844

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00436-16

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27044556

http://www.w3.org/2001/XMLSchema#string

P921

Acinetobacter baumannii

carbapenem antibiotic

P932

4879382

http://www.w3.org/2001/XMLSchema#string